Talk:Diffuse intrinsic pontine glioma

T cell therapy starts clinical trial

[1] mentions selecting T cells that target histone 3 variant 3. Could mention in Research ? - Rod57 (talk) 12:53, 6 December 2017 (UTC)

Feb. 2019: This is an article about a disease, isn't it?

Why is this article so limited in its scope? Looks like the editors have tailored it around their chosen/available sources. A WP article about a disease generally has a symptoms section, an epidemiology section, and a history section, for starters. Would somebody with an interest in this subject kindly create one or more of the above-mentioned sections, so that this article is useful?--Quisqualis (talk) 05:30, 25 February 2019 (UTC)

DIPG is no longer an up-to-date diagnosis

In 2016, the World Health Organization (WHO) elected to deprecate the term Diffuse intrinsic pontine glioma. Tumors previously diagnosed as DIPG are instead classified by their mutation status into various categories, but primarily "Diffuse Midline Glioma, H3K27M mutant". (Some doctors still use the term DIPG, however.) This is probably why the article is so sparse. Authors should consider redirecting DIPG to Diffuse Midline Glioma, H3K27M mutant. But that article does not exist yet. It does seem important, as 100-250 children in the US are diagnosed with DMG each year, and it has no treatment. I would write it myself, but it seems like a big change to make unilaterally.VideoEtTaceo3 (talk) 01:59, 4 August 2019 (UTC)

I support moving the article.

The 2021 definition now lists them as "diffuse midline glioma, H3 K27-altered", and retains DIPG as a an acceptable name for those located in the pons. I suggest a move move to Diffuse midline glioma, which is unambiguous and a bit less of a mouthful. MaligneRange (talk) 14:23, 2 December 2023 (UTC)

References

No symptoms or diagnosis

There isn't anything in the article about presenting symptoms and diagnostic criteria TheDrD1ng3r (talk) 19:35, 13 March 2023 (UTC)